These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 38337711)

  • 41. Nutrition in Cirrhosis.
    Palmer LB; Kuftinec G; Pearlman M; Green CH
    Curr Gastroenterol Rep; 2019 Jul; 21(8):38. PubMed ID: 31289936
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Recent Progress of Nutritional Management for Liver Cirrhosis.
    Kawaguchi T; Kato A
    J Nutr Sci Vitaminol (Tokyo); 2022; 68(Supplement):S73-S75. PubMed ID: 36437024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Double burden of malnutrition in persons with obesity.
    Barazzoni R; Gortan Cappellari G
    Rev Endocr Metab Disord; 2020 Sep; 21(3):307-313. PubMed ID: 32766943
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis.
    Montano-Loza AJ; Angulo P; Meza-Junco J; Prado CM; Sawyer MB; Beaumont C; Esfandiari N; Ma M; Baracos VE
    J Cachexia Sarcopenia Muscle; 2016 May; 7(2):126-35. PubMed ID: 27493866
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nutritional Management of a Liver Transplant Candidate.
    Mishra S; Premkumar M
    J Clin Exp Hepatol; 2023; 13(5):878-894. PubMed ID: 37693267
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cause and management of muscle wasting in chronic liver disease.
    Dasarathy S
    Curr Opin Gastroenterol; 2016 May; 32(3):159-65. PubMed ID: 26974417
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Branched-chain amino acids as a protein- and energy-source in liver cirrhosis.
    Moriwaki H; Miwa Y; Tajika M; Kato M; Fukushima H; Shiraki M
    Biochem Biophys Res Commun; 2004 Jan; 313(2):405-9. PubMed ID: 14684176
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sarcopenic obesity in cirrhosis-The confluence of 2 prognostic titans.
    Eslamparast T; Montano-Loza AJ; Raman M; Tandon P
    Liver Int; 2018 Oct; 38(10):1706-1717. PubMed ID: 29738109
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Liver cirrhosis and encephalopathy: clinical and metabolic consequences and nutritional support].
    Mesejo A; Juan M; Serrano A
    Nutr Hosp; 2008 May; 23 Suppl 2():8-18. PubMed ID: 18714406
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sarcopenic obesity in patients awaiting liver transplant: Unique challenges for nutritional recommendations.
    Herscovici DM; Cooper KM; Colletta A; Rightmyer M; Shingina A; Feld LD
    World J Transplant; 2024 Jun; 14(2):90202. PubMed ID: 38947969
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sarcopenia impairs prognosis of patients with liver cirrhosis.
    Hanai T; Shiraki M; Nishimura K; Ohnishi S; Imai K; Suetsugu A; Takai K; Shimizu M; Moriwaki H
    Nutrition; 2015 Jan; 31(1):193-9. PubMed ID: 25441595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Micronutrient Intake in the Etiology, Prevention and Treatment of Osteosarcopenic Obesity.
    Kelly OJ; Gilman JC; Kim Y; Ilich JZ
    Curr Aging Sci; 2016; 9(4):260-278. PubMed ID: 27156952
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sarcopenic obesity: Time to meet the challenge.
    Barazzoni R; Bischoff SC; Boirie Y; Busetto L; Cederholm T; Dicker D; Toplak H; Van Gossum A; Yumuk V; Vettor R
    Clin Nutr; 2018 Dec; 37(6 Pt A):1787-1793. PubMed ID: 29857921
    [TBL] [Abstract][Full Text] [Related]  

  • 54. From the Bench to the Bedside: Branched Amino Acid and Micronutrient Strategies to Improve Mitochondrial Dysfunction Leading to Sarcopenia.
    Romani M; Berger MM; D'Amelio P
    Nutrients; 2022 Jan; 14(3):. PubMed ID: 35276842
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. EASL Clinical Practice Guidelines on nutrition in chronic liver disease.
    ;
    J Hepatol; 2019 Jan; 70(1):172-193. PubMed ID: 30144956
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nutritional care in hospitalized patients with chronic liver disease.
    Huynh DK; Selvanderan SP; Harley HA; Holloway RH; Nguyen NQ
    World J Gastroenterol; 2015 Dec; 21(45):12835-42. PubMed ID: 26668507
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiological Quantification of Sarcopenic Obesity and its Role in Chronic Liver Disease Severity.
    Cimsit C; Kursun M; Demircioglu O; Dilber F; Demirtas CO; Ergenc I
    Acad Radiol; 2023 Sep; 30 Suppl 1():S124-S131. PubMed ID: 37012127
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sarcopenic obesity and hypertension in elderly patients: a narrative review of pathophysiology and management strategies.
    Jurdana M; Žiberna L
    Ann Ist Super Sanita; 2023; 59(3):231-239. PubMed ID: 37712242
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sarcopenia in chronic liver disease: mechanisms and countermeasures.
    Allen SL; Quinlan JI; Dhaliwal A; Armstrong MJ; Elsharkawy AM; Greig CA; Lord JM; Lavery GG; Breen L
    Am J Physiol Gastrointest Liver Physiol; 2021 Mar; 320(3):G241-G257. PubMed ID: 33236953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.